During the past decade, Hawthorne Medical Research, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hawthorne Medical Research, Inc." are "Postmenopausal Vulvovaginal Atrophy" (1 trials) and "Vulvovaginal Atrophy" (1 trials). Many other conditions were trialed in "Hawthorne Medical Research, Inc." in a lesser frequency.

Most popular intervention types in "Hawthorne Medical Research, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "WC3011 Estradiol Vaginal Cream" (2 trials) and "Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hawthorne Medical Research, Inc." are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hawthorne Medical Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hawthorne Medical Research, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hawthorne Medical Research, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".